May/June 2013

Managing Antibiotic Resistance—An Imperative for Future Medical Care

June 06, 2013

The American Journal of Pharmacy Benefits

In this case study, the authors illustrate the diagnosis of institutional antibiotic resistance issues and drivers, and provide tailored recommendations for simultaneously reducing resistance, antibiotic costs, and treatment failure.

Economic Model Comparing Rivaroxaban and Enoxaparin for Post-Orthopedic VTE Prophylaxis

June 06, 2013

The American Journal of Pharmacy Benefits

This analysis evaluates-from a US payer's perspective-the economic impact of using rivaroxaban versus enoxaparin for thromboprophylaxis following total hip or knee replacement surgery.